Analytical Data
-
Gene name
MUCL1
- Application
-
Alternative Names
MUCL1; Mucin-Like Protein 1; Protein BS106; Mucin-like protein 1
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
Q96DR8
-
Expression Region
Asn21~Pro90
-
Molecular Weight
36.9kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MUSTN1, or MUSCLE-SPECIFIC RNA-BINDING PROTEIN 1, is a member of the RNA-binding protein family and plays a crucial role in muscle development and function. Research has indicated that MUSTN1 is involved in the regulation of myogenesis, the process by which muscle fibers are formed, and its expression is typically elevated in muscle tissues. Studies have suggested that MUSTN1 may interact with various signaling pathways, influencing muscle regeneration and repair following injury. Additionally, aberrant expression of MUSTN1 has been linked to certain muscle disorders and conditions, making it a potential biomarker for muscle-related diseases. Given its significance, the study of recombinant MUSTN1 protein has gained attention for its potential applications in understanding muscle pathophysiology and therapeutic developments. Through the generation of this recombinant protein, researchers aim to explore its molecular functions, interactions with other cellular components, and its role in muscle adaptation to stress or injury. Further investigation into the biochemical properties and mechanistic pathways involving MUSTN1 could provide insights into targeted therapies for muscle degeneration, ultimately contributing to improved treatment strategies for muscle diseases.
